Meningococcal vaccine group C conjugate (Nuron Biotech/Pfizer)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMeningococcal vaccine group C conjugate (Nuron Biotech/Pfizer)

Drug Alias NameMeningitecMnCCMnCCV- CRM(197)

ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Biological material > Bacterial vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsMeningitis, Meningococcal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesWyeth Llc

Active IndicationsMeningitis, Meningococcal

Inactive IndicationsN/A

Other Information

ATC CodeJ07AH07